Key Events This Week
10 Aug: Stock opens at Rs.844.00, down 4.49%
11 Aug: Intraday high of Rs.919 with 8.29% close gain
12 Aug: Technical momentum shifts bullish with 11.77% surge to Rs.943.35
13 Aug: Continued gains, closing at Rs.947.85 (+5.89%)
14 Aug: Week closes at Rs.949.45 (+0.17%)
10 August 2026: Sharp Opening Decline Amid Market Stability
Windlas Biotech began the week on a weak note, closing at Rs.844.00, down 4.49% or Rs.39.65 from the previous close. This decline contrasted with the Sensex’s modest gain of 0.09%, closing at 37,131.97. The stock’s volume was relatively low at 5,797 shares, indicating subdued trading interest. This initial weakness set the stage for a volatile week ahead.
11 August 2026: Intraday High and Strong Rebound
On 11 August, Windlas Biotech staged a remarkable recovery, surging 11.77% intraday to reach a high of Rs.919, before settling at Rs.943.35, an 8.29% gain from the prior close. The stock demonstrated significant volatility, swinging from an intraday low of Rs.819 (-2.96%) to the high, reflecting active trading and strong buying interest. This performance notably outpaced the Sensex, which declined 0.28% to 37,029.82. Volume surged to 47,828 shares, confirming robust market participation.
Technical indicators supported this rally, with the stock trading above all key moving averages, signalling sustained momentum. The outperformance relative to the Pharmaceuticals & Biotechnology sector and the broader market highlighted Windlas Biotech’s resilience amid sectoral challenges.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
12 August 2026: Technical Momentum Shift Spurs 11.77% Surge
The bullish momentum intensified on 12 August as Windlas Biotech’s stock price surged 11.77% to close at Rs.943.35, from Rs.844.00 the previous day. The intraday range was wide, with a low of Rs.819.00 and a high of Rs.960.00, reflecting heightened volatility and strong investor interest. This price action marked a significant technical shift from mildly bullish to bullish, supported by improved moving averages and positive weekly MACD readings.
Despite the broader market’s weakness, with the Sensex falling 0.17% to 36,967.15, Windlas Biotech’s outperformance was notable. The stock’s relative strength was further underscored by its year-to-date return of 18.65%, far exceeding the Sensex’s negative 8.29%. However, volume-based indicators such as On-Balance Volume remained subdued, suggesting cautious confirmation of the rally.
13 August 2026: Continued Gains Amid Mixed Market Signals
On 13 August, Windlas Biotech maintained its upward trajectory, closing at Rs.947.85, up 5.89% from the previous day. The Sensex also rebounded slightly, gaining 0.16% to 37,024.45. The stock’s volume was moderate at 11,696 shares, indicating steady investor interest. Technical indicators remained supportive, with the stock trading comfortably above its 20-day and 50-day moving averages, reinforcing the bullish trend.
14 August 2026: Week Ends with Modest Gain
The week concluded on 14 August with Windlas Biotech edging up 0.17% to Rs.949.45, marking the week’s closing high. The Sensex declined 0.17% to 36,962.93, extending its weekly loss. Volume was relatively low at 4,229 shares, suggesting a consolidation phase after the week’s strong gains. The stock’s technical outlook remains cautiously optimistic, with key support near Rs.840 and resistance around Rs.1,000.
Is Windlas Biotech Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Daily Price Comparison: Windlas Biotech vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-10 | Rs.844.00 | -4.49% | 37,131.97 | +0.09% |
| 2026-08-11 | Rs.943.35 | +11.77% | 37,029.82 | -0.28% |
| 2026-08-12 | Rs.895.15 | -5.11% | 36,967.15 | -0.17% |
| 2026-08-13 | Rs.947.85 | +5.89% | 37,024.45 | +0.16% |
| 2026-08-14 | Rs.949.45 | +0.17% | 36,962.93 | -0.17% |
Key Takeaways
Strong Weekly Outperformance: Windlas Biotech’s 7.45% weekly gain sharply contrasts with the Sensex’s 0.37% decline, highlighting the stock’s resilience and relative strength in a subdued market environment.
Volatility and Momentum Shifts: The week was marked by significant intraday volatility, especially on 11 and 12 August, with the stock hitting an intraday high of Rs.919 and surging 11.77% on 12 August. These moves were supported by bullish technical indicators, including moving averages and MACD.
Technical Indicators Mixed but Positive: While weekly and daily indicators signal bullish momentum, monthly indicators and volume-based metrics suggest some caution, indicating the need for monitoring key support and resistance levels.
Sector and Market Context: Despite challenges in the Pharmaceuticals & Biotechnology sector and a broadly weak Sensex, Windlas Biotech’s technical upgrades and price action demonstrate its capacity to outperform peers and the market.
Conclusion
Windlas Biotech Ltd’s performance over the week ending 14 August 2026 reflects a robust technical rebound and strong relative strength amid a challenging market backdrop. The stock’s ability to recover from an early-week decline and sustain gains above key moving averages underscores a positive shift in momentum. However, mixed signals from volume indicators and longer-term technical measures counsel a measured approach. Investors and market participants should watch for confirmation of support near Rs.840 and resistance around Rs.1,000 to gauge the sustainability of this rally. Overall, Windlas Biotech’s weekly gains and technical developments position it as a noteworthy performer within the small-cap pharmaceutical space.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
